Dublin, July 17, 2019 (GLOBE NEWSWIRE) -- The "Nanopharmaceuticals Market: Global Industry Analysis, Trends, Market Size, and Forecasts up to 2025" report has been added to ResearchAndMarkets.com's offering.

The report predicts the global nanopharmaceuticals market to grow with a CAGR of 22.1% over the forecast period from 2019-2025.

The report on the global nanopharmaceuticals market provides qualitative and quantitative analysis for the period from 2017 to 2025. The study on nanopharmaceuticals market covers the analysis of the leading geographies such as North America, Europe, Asia-Pacific, and RoW for the period of 2017 to 2025.

The report on nanopharmaceuticals market is a comprehensive study and presentation of drivers, restraints, opportunities, demand factors, market size, forecasts, and trends in the global nanopharmaceuticals market over the period of 2017 to 2025. Moreover, the report is a collective presentation of primary and secondary research findings.

Porter's five forces model in the report provides insights into the competitive rivalry, supplier and buyer positions in the market and opportunities for the new entrants in the global nanopharmaceuticals market over the period of 2017 to 2025. Further, Growth Matrix gave in the report brings an insight into the investment areas that existing or new market players can consider.

Report Findings

1) Drivers

  • Rising prevalence of chronic and neurological diseases
  • Rising prevalence of neurological disorders
  • Increasing awareness about advantages offered by nanopharmaceuticals
  • Growing government funding to support the development of regenerative medicine

2) Restraints

  • Lack of regulatory procedures

3) Opportunities

  • Research and development happening in nanopharmaceuticals

What does this report deliver?

1. Comprehensive analysis of the global as well as regional markets of the nanopharmaceuticals market.
2. Complete coverage of all the segments in the nanopharmaceuticals market to analyze the trends, developments in the global market and forecast of market size up to 2025.
3. Comprehensive analysis of the companies operating in the global nanopharmaceuticals market. The company profile includes analysis of product portfolio, revenue, SWOT analysis and latest developments of the company.
4. Growth Matrix presents an analysis of the product segments and geographies that market players should focus to invest, consolidate, expand and/or diversify.

Key Topics Covered

1. Preface
1.1. Report Description
1.2. Research Methods
1.3. Research Approaches

2. Executive Summary
2.1. Nanopharmaceuticals Market Highlights
2.2. Nanopharmaceuticals Market Projection
2.3. Nanopharmaceuticals Market Regional Highlights

3. Global Nanopharmaceuticals Market Overview
3.1. Introduction
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
3.3. Porter's Five Forces Analysis
3.4. Growth Matrix Analysis
3.4.1. Growth Matrix Analysis by Application
3.4.2. Growth Matrix Analysis by Region
3.5. Value Chain Analysis of Nanopharmaceuticals Market

4. Nanopharmaceuticals Market Macro Indicator Analysis

5. Global Nanopharmaceuticals Market by Application
5.1. Drug Delivery
5.2. Oncology
5.3. Neurology
5.4. Anti-inflammatory
5.5. Anti-infective
5.6. Other Applications

6. Global Nanopharmaceuticals Market by Region
6.1. North America
6.2. Europe
6.3. Asia-Pacific
6.4. RoW

7. Company Profiles and Competitive Landscape
7.1. Competitive Landscape in the Global Nanopharmaceuticals Market
7.2. Companies Profiled
7.2.1. NanoPharmaceuticals LLC
7.2.2. Cambrex Corporation
7.2.3. Pfizer CentreOne
7.2.4. PharmaCircle
7.2.5. Baxter BioPharma Solutions LLC
7.2.6. BASF Corporation
7.2.7. Croda Healthcare
7.2.8. Frontage Laboratories Inc

For more information about this report visit https://www.researchandmarkets.com/r/z9cuia

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceuticals